3 results match your criteria: "the Clinical Second Clinical Medical College of Yangtze University[Affiliation]"
Future Oncol
June 2020
Department of Gastrointestinal Surgery, Jingzhou Central Hospital, the Clinical Second Clinical Medical College of Yangtze University, Jingzhou, Hubei, Renmin Road 1, Jingzhou, 434020, PR China.
Clinical management of colorectal cancer is challenging. Circulating tumor cells (CTCs) and DNA (ctDNA) are investigated to detect key mutation and for prognosis for risk stratifications. 200 advance-stage patients with metastatic disease were selected and followed-up.
View Article and Find Full Text PDFAnticancer Drugs
September 2019
Department of Obstetrics and Gynecology, Jingzhou Central Hospital, the Clinical Second Clinical Medical College of Yangtze University, Jingzhou, Hubei, People's Republic of China.
Aberrant activation of Ras is common in several human cancers, including cervical cancer. In this study, we show that Ras function can be inhibited by zoledronic acid (ZA) owing to its ability in inhibiting protein prenylation. Using in-vitro cell culture system and an in-vivo xenograft mouse model, the effects of ZA on cervical cancer cell growth and survival were determined.
View Article and Find Full Text PDFBiomed Pharmacother
March 2018
Department of Obstetrics and Gynecology, Jingzhou Central Hospital, The Clinical Second Clinical Medical College of Yangtze University, Jingzhou, Hubei, China. Electronic address:
Isoprenylcysteine carboxylmethyltransferase (Icmt) catalyzes the last step of post-translational protein prenylation, which is essential for the stability and proper functions of many oncogenic proteins, such as Ras. Despite extensive studies on the roles of Icmt in tumor transformation and progression, little is known on the involvement ofIcmt in the development of tumor resistance to chemotherapy. Here we show the upregulation of Icmt as a persistent response to chemotherapy in cervical cancer cells.
View Article and Find Full Text PDF